Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 0.15% is 102% above its 5-year average of -7.44%, near the high end of its 5-year range (-32.64%–7.96%).
250.81% above its 12-month average of -0.10%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -0.16%.
EBITDA MARGIN
0.15%
EBITDA MARGIN AVG TTM
-0.10%
EBITDA MARGIN AVG 3Y
-1.27%
EBITDA MARGIN AVG 5Y
-7.44%
EBITDA MARGIN AVG 10Y
-13.52%
EBITDA MARGIN AVG 15Y
-21.09%
EBITDA MARGIN AVG 20Y
-30.96%
CURRENT VS TTM AVG
+250.81%
CURRENT VS 3Y AVG
+111.80%
CURRENT VS 5Y AVG
+102.02%
CURRENT VS 10Y AVG
+101.11%
CURRENT VS 15Y AVG
+100.71%
CURRENT VS 20Y AVG
+100.48%
Market Cap
$2.01B
EBITDA Margin
1.74%
TTM Avg
-0.52%
3Y Avg
3.36%
5Y Avg
2.51%
Market Cap
$2.02B
EBITDA Margin
40.34%
TTM Avg
23.31%
3Y Avg
-20.04%
5Y Avg
-112.62%
Market Cap
$2.02B
EBITDA Margin
-3042.18%
TTM Avg
-3200.65%
3Y Avg
-2392.49%
5Y Avg
-2392.49%
Market Cap
$2.05B
EBITDA Margin
7.12%
TTM Avg
6.21%
3Y Avg
-1.19%
5Y Avg
-11.55%
Market Cap
$1.96B
EBITDA Margin
-13.52%
TTM Avg
-19.53%
3Y Avg
-24.36%
5Y Avg
-23.78%
Market Cap
$1.95B
EBITDA Margin
-4034.86%
TTM Avg
-3070.57%
3Y Avg
-2386.79%
5Y Avg
-1872.66%
Market Cap
$2.06B
EBITDA Margin
39.14%
TTM Avg
19.43%
3Y Avg
-11.55%
5Y Avg
-189.29%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AxoGen, Inc. (AXGN) | $2.00B | 0.15% | -0.10% | -1.27% | -7.44% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 1.74% | -0.52% | 3.36% | 2.51% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 40.34% | 23.31% | -20.04% | -112.62% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -3042.18% | -3200.65% | -2392.49% | -2392.49% |
| Azenta, Inc. (AZTA)vs › | $1.97B | 8.41% | 9.50% | 6.21% | 7.73% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 7.12% | 6.21% | -1.19% | -11.55% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -13.52% | -19.53% | -24.36% | -23.78% |
| Absci Corporation (ABSI)vs › | $1.95B | -4034.86% | -3070.57% | -2386.79% | -1872.66% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 39.14% | 19.43% | -11.55% | -189.29% |
| Alvotech (ALVO)vs › | $2.07B | 19.79% | 20.20% | -178.47% | -247.76% |
Gross Margin
74.6%
EBITDA Margin
0.1%
Operating Margin
-5.1%
Net Margin
-13.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -0.16% |
| 2026-03-31 | -1.15% |
| 2025-12-31 | -11.41% |
| 2025-09-30 | 6.06% |
| 2025-06-30 | 6.16% |
| 2025-03-31 | 0.46% |
| 2024-12-31 | 7.96% |
| 2024-09-30 | 3.39% |
| 2024-06-30 | 3.41% |
| 2024-03-31 | -6.44% |
| 2023-12-31 | -3.12% |
| 2023-09-30 | -6.34% |
| 2023-06-30 | -15.34% |
| 2023-03-31 | -16.63% |
| 2022-12-31 | -12.27% |
| 2022-09-30 | -9.69% |
| 2022-06-30 | -19.49% |
| 2022-03-31 | -32.64% |
| 2021-12-31 | -13.44% |
| 2021-09-30 | -17.71% |
| 2021-06-30 | -17.90% |
| 2021-03-31 | -15.79% |
| 2020-12-31 | -13.23% |
| 2020-09-30 | -0.45% |
| 2020-06-30 | -34.25% |
| 2020-03-31 | -31.72% |
| 2019-12-31 | -23.49% |
| 2019-09-30 | -19.00% |
| 2019-06-30 | -26.07% |
| 2019-03-31 | -40.92% |
| 2018-12-31 | -24.06% |
| 2018-09-30 | -20.37% |
| 2018-06-30 | -22.36% |
| 2018-03-31 | -27.77% |
| 2017-12-31 | -9.71% |
| 2017-09-30 | -8.42% |
| 2017-06-30 | -8.69% |
| 2017-03-31 | -25.07% |
| 2016-12-31 | -22.73% |
| 2016-09-30 | -9.55% |
| 2016-06-30 | -14.46% |
| 2016-03-31 | -31.17% |
| 2015-12-31 | -33.03% |
| 2015-09-30 | -22.72% |
| 2015-06-30 | -32.67% |
| 2015-03-31 | -50.30% |
| 2014-12-31 | -55.38% |
| 2014-09-30 | -37.43% |
| 2014-06-30 | -53.46% |
| 2014-03-31 | -93.88% |
| 2013-12-31 | -92.59% |
| 2013-09-30 | -75.89% |
| 2013-06-30 | -75.46% |
| 2013-03-31 | -106.68% |
| 2012-09-30 | -91.75% |
| 2012-06-30 | -74.84% |
| 2012-03-31 | -112.27% |
| 2011-12-31 | -139.46% |
| 2011-09-30 | -223.02% |
| 2011-06-30 | -118.11% |
| 2011-03-31 | -79.92% |
| 2010-12-31 | -1230.72% |
| 2010-09-30 | -109.05% |
| 2010-06-30 | -10231.78% |
| 2010-03-31 | -1893.24% |
| 2009-12-31 | 66.38% |
| 2009-09-30 | -520.14% |
| 2009-06-30 | 23.80% |
| 2009-03-31 | -305.53% |
| 2008-12-31 | -357.41% |
| 2008-09-30 | -4136.46% |
| 2008-06-30 | -3452.08% |
| 2008-03-31 | -770.60% |
| 2006-09-30 | -210.74% |
| 2006-03-31 | -61.05% |
| 2005-12-31 | 56.86% |
| 2005-09-30 | -21.76% |
| 2005-06-30 | -158.62% |
| 2005-03-31 | -459.53% |
| 2004-09-30 | -11.02% |
| 2004-06-30 | 6.10% |
| 2004-03-31 | -10.86% |
| 2003-12-31 | -3.13% |
| 2003-09-30 | 2.59% |
| 2003-06-30 | -18.09% |
| 2003-03-31 | -9.28% |
| 2002-12-31 | -28.54% |
| 2002-09-30 | -9.53% |
